GF
MRNA icon

Gabelli Funds’s Moderna MRNA Stock Holding History

Gabelli Funds’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.07M Buy
29,500
+23,500
+392% +$1.22M 0.01% 762
2026
Q1 		$305K Sell
6,000
-2,500
-29% -$117K ﹤0.01% 1110
2025
Q4 		$251K Sell
8,500
-1,500
-15% -$40.8K ﹤0.01% 1131
2025
Q3 		$258K Buy
10,000
+2,500
+33% +$69.7K ﹤0.01% 1126
2025
Q2 		$207K Buy
+7,500
New +$198K ﹤0.01% 1137
2021
Q3 		– Sell
-1,095
Closed -$257K – 1413
2021
Q2 		$257K Buy
+1,095
New +$196K ﹤0.01% 1178

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Gabelli Funds's MRNA Position: Q2 2026 in Review

Gabelli Funds increased its Moderna (MRNA) stake by 392% in Q2 2026, buying an estimated $1.22M and bringing the position to 29,500 shares worth $2.07M. The position accounts for 0.01% of the portfolio, ranked #762.

Gabelli Funds first reported a position in MRNA in Q2 2021 and has held it in 6 quarters since. 775 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Gabelli Funds held 29,500 shares of Moderna worth $2.07M as of Q2 2026.
  • Gabelli Funds bought 23,500 Moderna shares in Q2 2026, an estimated $1.22M.
  • Moderna made up 0.01% of Gabelli Funds's portfolio in Q2 2026, its #762 holding.
  • Gabelli Funds first reported a position in Moderna in Q2 2021 and has held it in 6 quarters since.
  • 775 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Gabelli Funds's 13F filing for Q2 2026, filed 12 Aug 2026.